CCL2 and neoplasm: Sorafenib also mediated the infiltration of tumor-associated neutrophils (TANs) in hepatocellular carcinoma patients and animal models, while TANs further promoted more intratumoral macrophages and T-regulatory (Treg) cells through secreting CCL2 and CCL17 [76].